Business
HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Signing of Binding Letter of Intent with Neurospa TMS Holdings, LLC for Expansion of its Planned International Network of Interventional Psychiatry Clinics
Neurospa currently operates six interventional psychiatry clinics on Florida's Gulf CoastHOPE to acquire majority interest in Neurospa for a combination of
About this update from Nrx Pharmaceuticals, Inc.
[{"type":"text","content":"Neurospa currently operates six interventional psychiatry clinics on Florida's Gulf CoastHOPE to acquire majority interest in Neurospa for a combination of cash and equityNeurospa clinics deliver a full range of interventional psychiatry services, including Ketamine, Spravato® and Transcranial Magnetic Stimulation (TMS) to patients with severe depression and related conditionsAcquisition to be accretive to HOPE revenue projections for 2025MIAMI, March 24, 2025 /PRNewswire/ -- HOPE Therapeutics, Inc., (\"HOPE,\" the \"Company\"), an interventional psychiatry network wholly owned by NRx Pharmaceuticals, Inc. (\"NRx\") (Nasdaq:NRXP), today announced signing of a binding Letter of Intent to acquire a majority interest in Neurospa TMS Holdings, LLC, LLC (Neurospa). Neurospa operates six interventional psychiatry clinics on Florida's Gulf Coast and will constitute a key element of HOPE's Florida network going forward. Neurospa is revenue generating and EBITDA positive.\n\n \n \n \n \n \n \n\n \nNeurospa leverages state-of-the-art interventional psychiatry procedures, including Ketamine Infusion Therapy, Transcranial Magnetic Stimulation (TMS), and Spravato®, augmented by traditional psychiatry and talk therapy to provide a full continuum of care for people with depression, suicidality, PTSD, anxiety, and related disorders. TMS is an FDA-approved procedure in which focused electromagnetic treatment has been demonstrated to reduce symptoms of depression. Ketamine and Spravato® are similarly known to reduce symptoms of depression and both forms of treatment are increasingly used in an additive manner.\nNeurospa provides a physician-led, welcoming spa-like environment that puts patient's needs and comfort first. Neurospa's outstanding team of dedicated professionals are to become key members of the HOPE team upon closing of the transaction.\n\"Neurospa was founded with the mission to provide TMS therapy for patients in the Tampa Bay area, and has grown to provide comprehensive, cutting-edge care to patients in our six clinics in west central Florida; the team has made great progress achieving this exceptional level of care. We're eager to accelerate that mission by joining the HOPE Network,\" said Renier Gobea, Founder of Neurospa.\n\"We are thrilled to welcome the Neurospa team to the HOPE network and look forward to the contribution the...